We are proud to introduce the easy-to-use and cost-effective Vanadis cfDNA platform. Analyzing the common chromosome abnormalities (21, 18, 13, X & Y), Vanadis automates all critical steps, from primary tube to final data analysis, without the use of PCR or sequencing.
